600-P: Real-Time CGM Coverage Eligibility Should Include Type 2 Diabetes Patients Treated with Less-Intensive Therapy

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 600-P
Author(s):  
THOMAS GRACE ◽  
JAY SALYER
Keyword(s):  
Type 2 Diabetes ◽  
Real Time ◽  
Intensive Therapy ◽  
Diabetes Patients

scholarly journals SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored

2012 ◽  
Vol 81 (9) ◽  
pp. 594-604 ◽  
Author(s):  
M. Vervloet ◽  
L. van Dijk ◽  
J. Santen-Reestman ◽  
B. van Vlijmen ◽  
P. van Wingerden ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Real Time ◽  
Oral Medication ◽  
Sms Reminders ◽  
Diabetes Patients

scholarly journals Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Feng-fei Li ◽  
Li-yuan Fu ◽  
Wen-li Zhang ◽  
Xiao-fei Su ◽  
Jin-dan Wu ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Treatment Group ◽  
Intensive Therapy ◽  
Glucose Monitoring ◽  
Mean Amplitude ◽  
Newly Diagnosed ◽  
Glucose Fluctuations ◽  
Diabetes Patients

To compare blood glucose fluctuations in type 2 diabetes mellitus (T2DM) patients were treated using three procedures: insulin intensive therapy which is continuous subcutaneous insulin infusion (CSII), MDI3 (three injections daily), and MDI4 (four injections daily). T2DM patients were hospitalized and were randomly assigned to CSII, aspart 30-based MDI3, and glargine based MDI4. Treatments were maintained for 2-3 weeks after the glycaemic target was reached. After completing the baseline assessment, 6-day continuous glucose monitoring (CGM) was performed before and after completion of insulin treatment. Treatment with CSII provided a greater improvement of blood glucose fluctuations than MDI (MDI3 or MDI4) therapy either in newly diagnosed or in long-standing T2DM patients. In long-standing diabetes patients, the MDI4 treatment group had significantly greater improvement of mean amplitude glycemic excursion (MAGE) than the MDI3 treatment group. However, in patients with newly diagnosed diabetes, there were no significant differences in the improvement of MAGE between MDI3 and MDI4 groups. Glargine based MDI4 therapy provided better glucose fluctuations than aspart 30-based MDI3 therapy, especially in long-standing T2DM patients, if CSII therapy was not available.

Serum Ferritin Status of Patients with Type 2 DM Attending OPD of BIRDEM General Hospital

2020 ◽  
Vol 11 (1) ◽  
pp. 7-10
Author(s):  
Khadiza Begum ◽  
Fahmida Islam ◽  
Farjana Aktar ◽  
Murshida Aziz ◽  
Tohfa E Ayub Tahiya
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Serum Ferritin ◽  
Study Groups ◽  
Acute Phase Reactant ◽  
The Body ◽  
Iron Stores ◽  
Normal Healthy Individual ◽  
Diabetes Patients

Background: In recent times much is talked about of serum ferritin, an acute phase reactant a marker of iron stores in the body and its association with diabetes mellitus. Studies implicate that increased body iron stores and subclinical hemochromatosis has been associated with the development of glucose intolerance, type 2 diabetes and its micro as well as macrovascular complications. Material & Methods: This study was carried out to examine and to observe for any relationship between serum ferritin with Type 2 diabetes mellitus. Our study populations were included 163. Among them 81 type 2 diabetes patients as a case (M=49,F=32, mean 44.68 age in years)and 82 normal healthy individual as a control ( M=35, F=47 , mean 34.71 in years). Results: Majority were healthy outpatients who had come for regular checkup and were matched with controls. Serum ferritin and FBS were estimated and other investigations. Results showed that although Serum ferritin was in the normal range value it was increased in type 2 diabetes patients than in controls and was statistically significant, we did get a positive correlation with duration of diabetes. It can be concluded that there were positive associations between serum ferritin and FBG, age, sex among study groups. Conclusion: In conclusion our study shows that there is significant correlation between increased serum ferritin in diabetes compared to individuals with normal blood sugars in this part and hyper ferritinemia may be one of the causes for development of insulin resistance before overt diabetes. Anwer Khan Modern Medical College Journal Vol. 11, No. 1: Jan 2020, P 7-10

Sign in / Sign up

Export Citation Format

Share Document